DMTK - DermTech, Inc.
NASDAQ
->
Healthcare
->
Diagnostics & Research
La Jolla,
United States
Type: Equity
DMTK price evolution
DMTK
| (in millions $) | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $98.97 | $123.8 | $148.08 | $179.91 |
| Short term investments | $53.64 | $53.46 | $54.05 | $48.45 |
| Net receivables | $6.1 | $5.96 | $5 | $3.85 |
| Inventory | $1.39 | $1.43 | $0.76 | $0.48 |
| Total current assets | $160.83 | $183.87 | $208.12 | $232.82 |
| Long term investments | ||||
| Property, plant & equipment | $29.59 | $28.61 | $28.21 | $12.29 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $33.23 | $32.25 | $31.4 | $15.48 |
| Total investments | $53.64 | $53.46 | $54.05 | $48.45 |
| Total assets | $194.06 | $216.11 | $239.52 | $248.31 |
| Current liabilities | ||||
| Accounts payable | $3 | $0.86 | $1.57 | $2.88 |
| Deferred revenue | $0.42 | $1.31 | $1.35 | $1.38 |
| Short long term debt | $1.71 | $1.83 | $1.81 | $1.57 |
| Total current liabilities | $16.99 | $15.09 | $14.42 | $12.18 |
| Long term debt | $22.07 | $22.42 | $21.49 | $6.28 |
| Total noncurrent liabilities | $22.09 | $22.45 | $21.62 | $6.43 |
| Total debt | $23.78 | $24.25 | $23.3 | $7.86 |
| Total liabilities | $39.08 | $37.53 | $36.04 | $18.61 |
| Shareholders' equity | ||||
| Retained earnings | -$294.82 | -$266.05 | -$236.47 | -$206.36 |
| Other shareholder equity | -$1.09 | -$0.86 | -$0.69 | -$0.12 |
| Total shareholder equity | $154.99 | $178.58 | $203.48 | $229.7 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $179.91 | $24.25 | $15.37 | $0.45 |
| Short term investments | $48.45 | $39.53 | ||
| Net receivables | $3.85 | $1.48 | $0.68 | $0.68 |
| Inventory | $0.48 | $0.1 | $0.04 | $0.04 |
| Total current assets | $232.82 | $66.88 | $17.15 | $0.54 |
| Long term investments | $146.35 | |||
| Property, plant & equipment | $12.29 | $2.73 | $0.98 | $0.98 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $15.48 | $2.9 | $1.06 | $146.35 |
| Total investments | $48.45 | $39.53 | $146.35 | |
| Total assets | $248.31 | $69.78 | $18.21 | $146.89 |
| Current liabilities | ||||
| Accounts payable | $2.88 | $1.57 | $1.61 | $0.03 |
| Deferred revenue | $1.38 | $1.54 | $1.39 | $1.39 |
| Short long term debt | $1.57 | $0.11 | $0.01 | |
| Total current liabilities | $12.18 | $5.42 | $5.72 | $0.04 |
| Long term debt | $6.28 | $0.23 | ||
| Total noncurrent liabilities | $6.43 | $0.86 | $5.03 | $5.03 |
| Total debt | $7.86 | $0.34 | $0.01 | |
| Total liabilities | $18.61 | $6.29 | $5.72 | $5.07 |
| Shareholders' equity | ||||
| Retained earnings | -$206.36 | -$126.36 | -$91.11 | $0.85 |
| Other shareholder equity | -$0.12 | -$0 | ||
| Total shareholder equity | $229.7 | $63.49 | $12.49 | $5 |
| (in millions $) | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 | 31 Jan 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3.57 | $4.23 | $3.72 | |
| Cost of revenue | $3.69 | $3.27 | $3.55 | |
| Gross Profit | -$0.12 | $0.96 | $0.16 | |
| Operating activities | ||||
| Research & development | $5.7 | $6.92 | $6.34 | |
| Selling, general & administrative | $23.44 | $23.88 | $24.02 | |
| Total operating expenses | $29.14 | $30.79 | $30.36 | |
| Operating income | -$29.26 | -$29.83 | -$30.19 | |
| Income from continuing operations | ||||
| EBIT | -$28.77 | -$29.58 | -$30.11 | |
| Income tax expense | ||||
| Interest expense | ||||
| Net income | ||||
| Net income | -$28.77 | -$29.58 | -$30.11 | |
| Income (for common shares) | -$28.77 | -$29.58 | -$30.11 | |
| (in millions $) | 31 Jan 2022 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $5.88 | $3.36 | ||
| Cost of revenue | $5.98 | $3.3 | ||
| Gross Profit | -$0.1 | $0.06 | ||
| Operating activities | ||||
| Research & development | $5.29 | $2.5 | ||
| Selling, general & administrative | $29.9 | $15.17 | ||
| Total operating expenses | $35.19 | $17.66 | $0.31 | |
| Operating income | -$35.29 | -$17.61 | -$0.31 | |
| Income from continuing operations | ||||
| EBIT | -$35.29 | -$17.03 | $0.86 | |
| Income tax expense | ||||
| Interest expense | -$0.04 | $2.66 | ||
| Net income | ||||
| Net income | -$35.25 | -$19.69 | $0.86 | |
| Income (for common shares) | -$35.25 | -$19.69 | $0.86 | |
| (in millions $) | 30 Sep 2022 | 30 Jun 2022 | 31 Mar 2022 | 31 Dec 2021 |
|---|---|---|---|---|
| Net income | -$28.77 | -$29.58 | -$30.11 | -$26.05 |
| Operating activities | ||||
| Depreciation | $1.1 | $1.07 | $0.81 | $0.73 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $4.94 | $4.84 | $3.89 | $3.83 |
| Total cash flows from operations | -$24.8 | -$24.41 | -$24.82 | -$22.68 |
| Investing activities | ||||
| Capital expenditures | -$0.01 | -$0.71 | -$0.65 | -$1.06 |
| Investments | -$0.45 | $0.85 | -$6.89 | -$3.47 |
| Total cash flows from investing | -$0.47 | $0.14 | -$7.53 | -$4.52 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.48 | $0.01 | $0.57 | $0.12 |
| Net borrowings | -$0.04 | -$0.02 | -$0.04 | -$0.09 |
| Total cash flows from financing | $0.43 | -$0.01 | $0.53 | $0.03 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$24.83 | -$24.27 | -$31.83 | -$27.18 |
| (in millions $) | 31 Dec 2021 | 31 Dec 2020 | 31 Dec 2019 | 31 Dec 2018 |
|---|---|---|---|---|
| Net income | -$78.33 | -$35.25 | -$19.69 | $0.86 |
| Operating activities | ||||
| Depreciation | $2.3 | $0.49 | $0.09 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $13.28 | $4.97 | $1.3 | |
| Total cash flows from operations | -$62.11 | -$28.68 | -$17.79 | -$0.37 |
| Investing activities | ||||
| Capital expenditures | -$2.72 | -$1.83 | -$0.21 | |
| Investments | -$9.79 | -$39.51 | -$145.19 | |
| Total cash flows from investing | -$12.51 | -$41.34 | -$0.21 | -$145.19 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $230.45 | $44.31 | $20.74 | $146.49 |
| Net borrowings | -$0.17 | -$0.01 | $2.08 | -$0.32 |
| Total cash flows from financing | $230.28 | $78.9 | $28.62 | $145.99 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $155.66 | $8.87 | $10.62 | $0.42 |
News
Fundamentals
| Market cap | $157.71M |
|---|---|
| Enterprise value | $82.52M |
| Shares outstanding | 30.21M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | 17.92% |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 1.01 |
| Book/Share | 5.17 |
| Cash/Share | 3.28 |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.08 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 9.47 |
| Quick ratio | 9.39 |